BioSpace News Archive

Arrowhead Pharmaceuticals, Inc. announced that as an inducement to entering into employment with the Company, on July 1, 2022, the Compensation Committee of the Company’s Board of Directors approved “inducement” grants to 34 new employees under Rule 5635 of the NASDAQ Listing Rules.

Mirum Pharmaceuticals, Inc. announced that on July 8, 2022, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 43,000 shares of common stock and 21,500 restricted stock units to seven new employees under Mirum’s 2020 Inducement Plan.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Infectious diseases are caused because of helpless sterilization and lacking or inappropriate individual cleanliness.

Fact.MR, a market research and competitive intelligence provider: The global sales of endoscopes is expected to surpass US$ 34 Bn by registering a staggering double digit CAGR of 10% in the forecast period 2022-2032.

Fact.MR, a market research and competitive intelligence provider: The aesthetic medicine market is expected to increase at a CAGR of 10.3% from 2022 to 2032, with revenues estimated at US$ 64.6 billion in 2021, according to a recently published Fact.MR report.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global self-injection devices market is expanding at a rapid pace due to high prevalence and incidence rate of chronic diseases, technological advancements, new product development and commercialization, and product differentiation strategies adopted by leading pharmaceutical companies across the globe.

The significant rise in the incidence of knee related issues among people across the world is boosting the global market for knee replacement devices, substantially.

Bionomics Limited announced that Dr. Errol De Souza, Executive Chairman of Bionomics, will participate in a panel on “Unmet Needs and Novel Therapies in Neuropsychiatry” at the William Blair Biotech Focus Conference taking place virtually and in-person in New York on July 12-13, 2022.

Sobi® announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and other indications of large unmet medical need in Europe and most international markets.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces that Gaurav Shah, M.D., Chief Executive Officer, will participate in a fireside chat at the William Blair Biotech Focus Conference 2022 on July 12-13, 2022, at the St. Regis Hotel in New York.